Dactolisib
Dactolisib is an orally bioavailable inhibitor of PI3K and mTOR (IC50s: 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR).
| Catalog Number | T2235 |
| Alternative Name(s) | BEZ235 , NVP-BEZ235 |
| Research Area | DNA Damage/DNA Repair|||PI3K/Akt/mTOR signaling|||Autophagy |
| Molecular Formula | C30H23N5O |
| CAS# | 915019-65-7 |
| Purity | 99.71% |
| SMILES | Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1 |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Dactolisib |
| Additional Information | https://www.targetmol.com/datasheet/T2235 |